Full history for every metric is available with a Kvantra account
Amplitude Surgical S.A. (AMPLI.PA)
Key financial summary
Financials in EUR| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 103 | 88 | 83 | 88 | 100 | 106 | 108 |
| Operating profit | €m | 13 | 12 | |||||
| Net profit | €m | -9 | -14 | -14 | -4 | 39 | 2 | 1 |
| EPS reported | € | 0.03 | 0.02 | |||||
| Operating cashflow per share | € | 0.08 | 0.08 | |||||
| Capex per share | € | 0.22 | 0.22 | |||||
| FCF per share | € | -0.13 | -0.13 | |||||
| Free cash flow | €m | -6 | -5 | |||||
| Net debt | €m | 77 | 85 | |||||
| Book value equity | €m | 96 | 95 | |||||
| Book value per share | € | 2.00 | 1.97 | |||||
| Number of shares | m | 47.97 | 47.97 | |||||
| DPS (TTM paid) | € | 0.00 | 0.00 |
Financial summary
Financials in EUR| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 105.33 | - | |||||
| P/B LTM | x | 1.69 | 3.17 | |||||
| P/S LTM | x | 1.53 | 2.76 | |||||
| P/FCF LTM | x | -25.58 | -64.65 | |||||
| EV/EBITDA LTM | x | 10.69 | 14.19 | |||||
| EV/Sales LTM | x | 2.38 | 3.55 | |||||
| Earnings Yield LTM | % | 0.95% | 0.51% | |||||
| FCF Yield | % | -3.91% | -1.55% | |||||
| Quality | ||||||||
| ROE | % | 1.59% | 1.59% | |||||
| ROIC | % | 5.31% | 5.31% | |||||
| Operating margin | % | 12.49% | 12.49% | |||||
| Gross margin | % | 35.09% | 35.09% | |||||
| FCF/Sales | % | -5.98% | -5.98% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -96.11% | - | |||||
| Sales Growth YoY | % | +5.81% | +4.23% | |||||
| Net Income Growth YoY | % | -96.11% | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | +64.48% | +29.23% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.05 | -0.04 | |||||
| Net Debt/EBITDA | x | 3.82 | 3.82 | |||||
| EBIT/Net interest | x | 1.31 | 1.31 | |||||
| Net debt/market cap | % | 47.60% | 28.40% | |||||
| Net debt/Equity | x | 0.81 | 0.90 | |||||
| Gross debt/equity | x | 1.24 | 1.24 | |||||
Company overview
Amplitude Surgical S.A. specializes in the design, development, and commercialization of surgical solutions for orthopedics. Its comprehensive portfolio addresses both primary and revision procedures, targeting a variety of conditions affecting the hip, knee, and lower limbs, with a particular focus on foot and ankle pathologies. This includes a wide array of knee and hip prostheses, as well as specialized implants for the foot and ankle. Beyond implants, Amplitude Surgical offers advanced technological platforms like AMPLIVISION, a computer-aided surgical system; i.M.A.G.E., a customized, single-use instrumentation solution; and E.T.O.I.L.E., an innovative platform facilitating less-invasive anterior surgical approaches. The company also supplies the necessary instrumentation for implant fitting. Operating globally, its products reach approximately 30 countries through an extensive network of distributors and agents, serving patients, surgeons, and healthcare institutions. Established in 1997, Amplitude Surgical S.A. maintains its headquarters in Valence, France.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Amplitude Surgical S.A. (AMPLI.PA)
Amplitude Surgical S.A. specializes in the design, development, and commercialization of surgical solutions for orthopedics. Its comprehensive portfolio addresses both primary and revision procedures, targeting a variety of conditions affecting the hip, knee, and lower limbs, with a particular focus on foot and ankle pathologies. This includes a wide array of knee and hip prostheses, as well as specialized implants for the foot and ankle. Beyond implants, Amplitude Surgical offers advanced technological platforms like AMPLIVISION, a computer-aided surgical system; i.M.A.G.E., a customized, single-use instrumentation solution; and E.T.O.I.L.E., an innovative platform facilitating less-invasive anterior surgical approaches. The company also supplies the necessary instrumentation for implant fitting. Operating globally, its products reach approximately 30 countries through an extensive network of distributors and agents, serving patients, surgeons, and healthcare institutions. Established in 1997, Amplitude Surgical S.A. maintains its headquarters in Valence, France.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free